DE68903988D1 - Acetylcystein enthaltende mundloesliche arzneimittel. - Google Patents

Acetylcystein enthaltende mundloesliche arzneimittel.

Info

Publication number
DE68903988D1
DE68903988D1 DE8989107231T DE68903988T DE68903988D1 DE 68903988 D1 DE68903988 D1 DE 68903988D1 DE 8989107231 T DE8989107231 T DE 8989107231T DE 68903988 T DE68903988 T DE 68903988T DE 68903988 D1 DE68903988 D1 DE 68903988D1
Authority
DE
Germany
Prior art keywords
acetylcystein
solutions containing
oral solutions
acetylcysteine
carbohydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989107231T
Other languages
English (en)
Other versions
DE68903988T2 (de
Inventor
Antonio Ziggiotti
Paolo Lualdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altergon SA
Original Assignee
Altergon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon SA filed Critical Altergon SA
Application granted granted Critical
Publication of DE68903988D1 publication Critical patent/DE68903988D1/de
Publication of DE68903988T2 publication Critical patent/DE68903988T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8989107231T 1988-04-29 1989-04-21 Acetylcystein enthaltende mundloesliche arzneimittel. Expired - Fee Related DE68903988T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20386/88A IT1217445B (it) 1988-04-29 1988-04-29 Composizione farmaceutiche orosolubili contenti acetilcisteina

Publications (2)

Publication Number Publication Date
DE68903988D1 true DE68903988D1 (de) 1993-02-04
DE68903988T2 DE68903988T2 (de) 1993-06-17

Family

ID=11166252

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989107231T Expired - Fee Related DE68903988T2 (de) 1988-04-29 1989-04-21 Acetylcystein enthaltende mundloesliche arzneimittel.

Country Status (6)

Country Link
US (1) US4970236A (de)
EP (1) EP0339508B1 (de)
AT (1) ATE83651T1 (de)
DE (1) DE68903988T2 (de)
ES (1) ES2052802T3 (de)
IT (1) IT1217445B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
DK0481294T4 (da) * 1990-10-19 2001-06-18 Spirig Ag Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
WO1995017900A1 (en) * 1993-12-30 1995-07-06 Arcturus Pharmaceutical Corporation Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
US5962421A (en) * 1996-05-16 1999-10-05 Zambon, S.A. Pharmacological association between N-acetylcysteine and levulose for preventing cellular death and related diseases
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
DE69612097D1 (de) * 1996-10-29 2001-04-19 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
WO1998021983A1 (en) * 1996-11-20 1998-05-28 Sang Whang Enterprises, Inc. Potassium and sodium bicarbonate for increased blood buffers
US6258848B1 (en) 1998-07-31 2001-07-10 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
US10139321B2 (en) * 2016-07-29 2018-11-27 Alpha-Tec Systems, Inc. Mucolytic tablet for a sample collection device
EP3678739B1 (de) 2017-09-07 2024-03-13 The Children's Hospital of Philadelphia Zusammensetzungen und verfahren zur behandlung der erblichen cystatin-c-amyloid-angiopathie (hccaa) und anderer neurodegenerativer erkrankungen, die mit aberranten amyloidablagerungen verbunden sind

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE304574C (de) *
US2888380A (en) * 1954-11-05 1959-05-26 Merck & Co Inc S-ethyl cysteine compositions for combatting tubercle bacilli
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1451177A (fr) * 1962-03-06 1966-01-07 Degussa Procédé de préparation d'une n-acylhomocystéine thiolactone
US3591686A (en) * 1967-08-01 1971-07-06 Mead Johnson & Co Anti-inflammatory compositions and methods utilizing n-acylcysteines and the beta-alkyl and carboxyl derivatives thereof
US3629452A (en) * 1968-02-19 1971-12-21 Oreal Method of reducing excessive secretions of sebum by oral administration of amino acid derivatives
USRE29256E (en) * 1969-10-07 1977-06-07 Recherche Pharmaceutiques Et Scientifiques Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
IT1194474B (it) * 1983-11-23 1988-09-22 Magis Farmaceutici Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
CH666814A5 (it) * 1986-07-24 1988-08-31 Inpharzam Int Sa Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.

Also Published As

Publication number Publication date
ES2052802T3 (es) 1994-07-16
DE68903988T2 (de) 1993-06-17
EP0339508A1 (de) 1989-11-02
ATE83651T1 (de) 1993-01-15
IT8820386A0 (it) 1988-04-29
IT1217445B (it) 1990-03-22
US4970236A (en) 1990-11-13
EP0339508B1 (de) 1992-12-23

Similar Documents

Publication Publication Date Title
DE68903988T2 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
ATE124951T1 (de) Fluorcytidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
MX9203480A (es) Formulaciones medicinales en aereosol.
PT841903E (pt) Composicao farmaceutica oral contendo agentes activos antimicrobianos e pantoprazole com libertacao diferida
DE3750431T2 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
ATE121089T1 (de) Optisch aktives 5h-pyrrolo(3,4-b>pyrazinderivat, seine herstellung und pharmazeutische zubereitungen die es enthalten.
DE3669103D1 (de) Ibuprofen enthaltendes arzneimittel.
NZ231508A (en) Hydroxamic acid derivatives, pharmaceutical compositions and intermediate compounds
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
FI870672A (fi) Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekretionshaemmande aemne.
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
EP0687464A3 (de) Verfahren zur Herstellung von Brausetabletten und Brausetabletten
DE69534283D1 (de) Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
NO893142D0 (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
PH27446A (en) Compound with gastric acid inhibitory effect
DE3782112D1 (de) Pyrimidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
ATE73668T1 (de) Karieshemmung.
DE68907392D1 (de) Dysmnesie modifizierende arzneimittel.
GB2021409A (en) Pharmaceutical composition
ATA36788A (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FI863470A0 (fi) 6-fenoximetyl-4 -hydroxitetrahydropyran-2-oner, foerfarande foer deras framstaellning, deras anvaendning som laekemedel farmaceutiska produkter och mellanprodukter.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee